In another study, Raspollini proved that immunostaining with antibodies anti-CDX-2, CK7, CK20, and CEA can be used to differentiate a primary bladder adenocarcinoma from a secondary colorectal adenocarcinoma [8]. Here, KRT7 is linked to bladder adenocarcinoma.